BioLife Solutions, Inc. (BLFS) Financials

BLFS Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 412.7 million 75.1 million
2023-09-30 411.2 million 79.1 million
2023-06-30 433.2 million 81.0 million
2023-03-31 446.5 million 88.4 million

BLFS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 1.3 million 8.3 million
2023-09-30 -5.9 million 9.1 million
2023-06-30 -8.3 million 6.9 million
2023-03-31 -6.0 million 7.4 million

BLFS Net Income

No data available :(

BLFS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 51.7 million - 17.5 million
2023-09-30 41.0 million - 18.2 million
2023-06-30 48.1 million - 19.1 million
2023-03-31 56.9 million - 18.3 million

BLFS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 44.8 million
2023-09-30 43.6 million
2023-06-30 43.4 million
2023-03-31 43.0 million

BLFS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 981000 4.4 million 13.0 million 4.5 million
2023-09-30 1.5 million 5.4 million 12.5 million 7.3 million
2023-06-30 609000 4.8 million 15.4 million 6.3 million
2023-03-31 3.3 million 4.2 million 14.8 million 6.5 million

BLFS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 32.7 million 24.4 million
2023-09-30 33.3 million 21.7 million
2023-06-30 39.5 million 27.7 million
2023-03-31 37.7 million 23.7 million

BLFS

Price: $17.53

52 week price:
8.92
24.50

Earnings Per Share: -1.52 USD

P/E Ratio: -7.87

Exchange: NCM

Sector: Healthcare

Industry: Medical Instruments & Supplies

Volume: 447300

Ebitda: -233997

Market Capitalization: 784.6 million

Links: